Loading...
Market
What will be the financial impact on Smiths Medical due to the tracheostomy tubes recall by end of 2024?
2
Resolution / Starting Odds
Revenue decrease > 10% • 25%
Revenue decrease ≤ 10% • 25%
No significant impact • 25%
Other • 25%
Smiths Medical financial reports and news analyses
Story
FDA Classifies Smiths Medical Tracheostomy Tubes Recall as Most Serious, 35 Injuries and 2 Deaths Reported
Sep 19, 2024, 05:40 PM
The U.S. Food and Drug Administration (FDA) has classified the recall of certain Bivona neonatal/pediatric and adult tracheostomy tubes made by Smiths Medical, a unit of ICU Medical, as the most serious type. This classification indicates that the defect could cause severe injury or death. The recall, which involves the removal of these tubes due to a manufacturing defect, has been linked to 35 reported injuries and two deaths. The FDA's action underscores the critical nature of the manufacturing defect in these medical devices.
View original story
Similar markets
Less than $100 million • 25%
$100 million to $500 million • 25%
$500 million to $1 billion • 25%
More than $1 billion • 25%
Less than $10 million • 33%
$10 million to $50 million • 33%
More than $50 million • 33%
Less than $100 million • 25%
$100 million - $199 million • 25%
$200 million - $299 million • 25%
$300 million or more • 25%
Revenue decrease due to MRT-6160 • 25%
Revenue increase due to MRT-6160 • 25%
No significant financial impact • 25%
MRT-6160 discontinued • 25%
No change • 25%
Decrease by less than 10% • 25%
Decrease by 10-20% • 25%
Decrease by more than 20% • 25%
Increase in sales • 25%
No change in sales • 25%
Moderate decrease in sales • 25%
Significant decrease in sales • 25%
Less than $2.5 billion • 25%
$2.5 billion to $3 billion • 25%
$3 billion to $3.5 billion • 25%
More than $3.5 billion • 25%
Less than $500 million • 25%
$500 million - $1 billion • 25%
$1 billion - $1.5 billion • 25%
More than $1.5 billion • 25%
Less than $10 million • 25%
$10 million - $50 million • 25%
$50 million - $100 million • 25%
More than $100 million • 25%
Significant revenue loss (>10%) • 25%
Moderate revenue loss (5-10%) • 25%
Minimal revenue loss (<5%) • 25%
No impact on revenue • 25%
Less than $100 million • 25%
$100 million to $500 million • 25%
$500 million to $1 billion • 25%
More than $1 billion • 25%
No significant financial impact • 25%
Impact between $1M and $10M • 25%
Impact between $10M and $50M • 25%
Impact over $50M • 25%